Cyclizine (Compound)

Synonyms:CYCLIZINE, 1-Benzhydryl-4-methylpiperazine, Marezine, 82-92-8, Nautazine, Ciclizina, Neo-devomit, 1-(Diphenylmethyl)-4-methylpiperazine, Valoid, N-Benzhydryl-N'-methylpiperazine, N-Methyl-N'-benzhydrylpiperazine, Cyclizinum, Cyclizinum [INN-Latin], Ciclizina [INN-Spanish], Compound 47-83, Piperazine, 1-(diphenylmethyl)-4-methyl-, (N-Benzhydryl)(N'-methyl)diethylenediamine, Wellcome preparation 47-83, 1-Benzhydryl-4-methylpiperazin, BW 47-83, Cyclizine chloride, Wellcome prepn. 47-83, Cyclizine (INN), NSC 26608, (+-)-1-diphenylmethyl-4-methylpiperazine, N-Methyl-N'-benzyhydrylpiperazine, 1-Diphenylmethyl-4-methylpiperazine, NSC-26608, QRW9FCR9P2, CHEBI:3994, 1-benzhydryl-4-methyl-piperazine, Emoquil, Wellcome, CYCLIZINE [INN], Ne-devomit, Wellcome prepn 47-83, HSDB 3309, NCGC00016421-01, CAS-303-25-3, EINECS 201-445-5, UNII-QRW9FCR9P2, BRN 0230441, SR-05000001595, Cyclizine [USP:INN:BAN:DCF], Emoquil (Salt/Mix), Marzine (Salt/Mix), Spectrum_000854, SpecPlus_000917, CYCLIZINE [MI], CYCLIZINE [HSDB], Prestwick0_000510, Prestwick1_000510, Prestwick2_000510, Prestwick3_000510, Spectrum2_001174, Spectrum3_000368, Spectrum4_000205, Spectrum5_001594, CYCLIZINE [VANDF], CHEMBL648, CYCLIZINE [MART.], CYCLIZINE [WHO-DD], SCHEMBL4690, Oprea1_429421, BSPBio_000439, BSPBio_002095, KBioGR_000809, KBioSS_001334, 5-23-01-00232 (Beilstein Handbook Reference), DivK1c_007013, SPECTRUM1500211, SPBio_001187, SPBio_002360, BPBio1_000483, GTPL7151, DTXSID4022864, KBio1_001957, KBio2_001334, KBio2_003902, KBio2_006470, KBio3_001315, N-Benzhydryl-N-methyl piperazine, HMS1920A20, HMS2091I08, Pharmakon1600-01500211, 1-Benzhydryl-4-methylpiperazine #, NSC26608, WLN: T6N DNTJ AYR&R& D1, CCG-40322, MFCD00023293, NSC756710, AKOS015839079, DB01176, NSC-756710, NCGC00016421-02, NCGC00016421-03, NCGC00016421-04, NCGC00016421-09, NCGC00094634-01, NCGC00094634-02, LS-14655, SBI-0052576.P003, (+/-)-1-diphenylmethyl-4-methylpiperazine, AB00053084, C06930, D03621, D81845, AB00053084_08, EN300-18073463, L000701, Q867308, SR-05000001595-1, BRD-K79501723-001-02-0, BRD-K79501723-003-03-4, BRD-K79501723-003-09-1

Pubchem:PUBCHEM:6726

Id:86ed776c-c99a-5a5a-92cf-779811ca9c9d

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Cyclizine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Cyclizine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Cyclizine.

Results found

Linked to

	Label	Description
	BRD-K79501723-003-09-1 Substance (Entity type)	A Substance
	cyclizine (e00135f2-a78b-4efb-a749-91ab270de2a9) Collection (Entity type)	Metadatata for cyclizine
	DCSTRUCT ID 00749 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00749; PubChem_CID:6726, FILE=drugcentral_drug_00749.json)
	Cyclizine negatively regulates CXCL8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cyclizine in similarity relationship with Linsidomine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cyclizine bioactivity 5-hydroxytryptamine receptor 2A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cyclizine negatively regulates MMP12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cyclizine positively regulates ARID4B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cyclizine positively regulates ADCY9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cyclizine negatively regulates ATF3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS